2 Biotech Stocks to Buy Hand Over Fist in August

Both of these biotechs are highly innovative companies. We are still in a bull market, but the biotech industry, as measured by the SPDR S&P Biotech ETF (an industry benchmark), hasn't been keeping up with broader equities this year. That's no reason to avoid biotech stocks -- after all, some are doing just fine. That's the case with Vertex Pharmaceuticals (VRTX -0.41%) and Sarepta Therapeutics (SRPT 0.87%). Although these drugmakers continue to perform well, both look to have plenty of upside. Let's find o ...